Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 74

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 74
---
., (b) 44,636 common shares held by Mr. Segal (c) 2,333,430 common shares issuable upon the exercise of options granted to Mr. Segal that are currently exercisable and (d) 52,850 common shares issuable upon the settlement of RSUs granted to Mr. Segal. Mr. Segal resigned as our President and Chief Executive Officer and as a member of our board of directors, effective April 11, 2025. Mr. Segal is included in this table because he is a named executive officer for the year ended December 31, 2024, but he is not counted for purposes of aggregating beneficial ownership of our executive officers and directors as a group. |

| (7) | Consists of (a) 209,663 common shares held by Dr. Koehler (b) 514,904 common shares issuable upon the exercise of options granted to Dr. Koehler that are currently exercisable and (c) 10,112 common shares issuable upon the settlement of RSUs granted to Dr. Koehler. Dr. Koehler departed from her position as our Executive Vice President, Chief Medical Officer, effective March 31, 2025. Dr. Koehler is included in this table because she is a named executive officer for the year ended December 31, 2024, but she is not counted for purposes of aggregating beneficial ownership of our executive officers and directors as a group. |

| (8) | Consists of (a) 48,781 common shares held by Dr. Zinda and (b) 518,530 common shares issuable upon the exercise of options granted to Dr. Zinda that are currently exercisable or will become exercisable within 60 days of April 15, 2025. |

| (9) | Consists of (a) 23,276 common shares held by Mr. Forte and (b) 612,714 common shares issuable upon the exercise of options granted to Mr. Forte that are currently exercisable or will become exercisable within 60 days of April 15, 2025. |

| (10) | Consists of (a) 7,500 common shares held by Mr. Civik and (b) 143,133 common shares issuable upon the exercise of options granted to Mr. Civik that are currently exercisable or will become exercisable within 60 days of April 15, 202